-
Entity
-
Individual
-
Location
-
C/O Myovant Sciences Inc., 320 West 37 Th Street, 5 Th Floor, New York, New York
-
Summary
-
The estimated net worth of Terrie Curran is at least $3.93 M dollars as of June 18, 2024. Terrie Curran is the President and Chief Executive, Director of Phathom Pharmaceuticals, Inc. and owns shares of Phathom Pharmaceuticals, Inc. (PHAT) stock worth about $3.78 M. Terrie Curran is the Director of Arcutis Biotherapeutics, Inc. and owns shares of Arcutis Biotherapeutics, Inc. (ARQT) stock worth about $151 K.